← back to search

Mark C. Markowski

University of Baltimore · US
Area of research
Pulmonary and Respiratory Medicine · Nutrition and Dietetics
Research interest
Research interests include Prostate Cancer Treatment and Research, Vitamin C and Antioxidants Research, Cancer, Lipids, and Metabolism, and Prostate Cancer Diagnosis and Treatment.
h-index
30
citations
2,745
works
327
NIH funding
primary concept
Medicine
email

Recent publications

National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations
Journal of Clinical Oncology 2025cited by 3position: middledoi
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial
Nature Communications 2024cited by 47position: firstdoi
Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images
Modern Pathology 2023cited by 25position: middledoi
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial
Journal of Clinical Oncology 2022cited by 39position: middledoi
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer
Journal of Clinical Oncology 2021cited by 135position: middledoi
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
European Urology 2021cited by 99position: middledoi
Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors
JNCI Cancer Spectrum 2019cited by 206position: middledoi
The Microbiome and Genitourinary Cancer: A Collaborative Review
European Urology 2019cited by 175position: firstdoi
Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies
Prostate Cancer and Prostatic Diseases 2018cited by 145position: middledoi
Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA‐repair gene mutations in prostate cancer
The Prostate 2018cited by 137position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Emmanuel S. Antonarakis · University of Minnesota4 papers (2018–2024)Tamara L. Lotan · Johns Hopkins Hospital3 papers (2018–2023)Tracy Jones · University of South Florida2 papers (2023–2024)Angelo M. De Marzo · Sidney Kimmel Cancer Center2 papers (2023–2024)Kenneth J. Pienta · University of Baltimore2 papers (2018–2021)Channing J. Paller · University Hospitals Seidman Cancer Center2 papers (2021–2024)Michael A. Carducci · University College London2 papers (2021–2024)Karen S. Sfanos · Johns Hopkins University2 papers (2018–2019)Pedro Isaacsson Velho · Twitter (United States)2 papers (2018–2021)Naomi B. Haas · Samsung Medical Center1 papers (2019–2019)Christopher A. French · University of Virginia1 papers (2019–2019)Catherine H. Marshall · Johns Hopkins Medicine1 papers (2024–2024)David E. Sanin · Bloomberg (United States)1 papers (2024–2024)Matthew Abramowtiz · University of Miami1 papers (2021–2021)Christine L. Hann · Johns Hopkins University1 papers (2019–2019)Carolina Gomes‐Alexandre · Johns Hopkins Medicine1 papers (2024–2024) · 1 papers (2019–2019)Alan Pollack · University of Miami1 papers (2021–2021)Eric Erak · Johns Hopkins Medicine1 papers (2023–2023)John L. Silberstein · Biogen (United States)1 papers (2018–2018)